Clinical Trial Update: Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B [Phase 2]

View source ↗

Summary

A Phase 2 long-term safety and efficacy study of LB80380 in treatment-naive patients with chronic hepatitis B is underway. The current status of the trial is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• LB80380

Snippet

Sponsor: LG Life Sciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: UNKNOWN